Atossa Therapeutics (FRA:YAG2) Purchase Of Property, Plant, Equipment : €-0.02 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Atossa Therapeutics Purchase Of Property, Plant, Equipment?

Atossa Therapeutics's purchase of property, plant, equipment for the three months ended in Mar. 2024 was €-0.01 Mil. It means Atossa Therapeutics spent €0.01 Mil on purchasing property, plant, equipment. Atossa Therapeutics's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Mar. 2024 was €-0.02Mil.

Compared with last quarter (€0.00 Mil in Dec. 2023 ), Atossa Therapeutics spent more money on purchasing property, plant, equipment in Mar. 2024 (€-0.01 Mil).

Atossa Therapeutics Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Atossa Therapeutics's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atossa Therapeutics Purchase Of Property, Plant, Equipment Chart

Atossa Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Property, Plant, Equipment

Get a 7-Day Free Trial

-0.01

-0.03

-0.01

Atossa Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Purchase Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-0.01	-	-	-0.01

Atossa Therapeutics Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02 Mil.

Atossa Therapeutics Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Atossa Therapeutics's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Atossa Therapeutics (FRA:YAG2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atossa Therapeutics Inc (FRA:YAG2) » Definitions » Purchase Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

ATOS:USA ATOS:Mexico YAG2:Germany

Address

107 Spring Street, Seattle, WA, USA, 98104

Website

https://www.atossatherapeutics.com

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Atossa Therapeutics (FRA:YAG2) Headlines

No Headlines